Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 Inhibition

Cancer Immunology Research
Hussein SultanEsteban Celis

Abstract

Peptide vaccines can be a successful and cost-effective way of generating T-cell responses against defined tumor antigens, especially when combined with immune adjuvants such as poly-IC. However, strong immune adjuvants can induce a collateral increase in numbers of irrelevant, nonspecific T cells, which limits the effectiveness of the peptide vaccines. Here, we report that providing prolonged IL2 signaling in the form of either IL2/anti-IL2 complexes or pegylated IL2 overcomes the competitive suppressive effect of irrelevant T cells, allowing the preferential expansion of antigen-specific T cells. In addition to increasing the number of tumor-reactive T cells, sustained IL2 enhanced the ability of T cells to resist PD-1-induced negative signals, increasing the therapeutic effectiveness of the vaccines against established tumors. This vaccination strategy using peptides and sustained IL2 could be taken into the clinic for the treatment of cancer. Cancer Immunol Res; 6(5); 617-27. ©2018 AACR.

References

Mar 1, 1991·Clinical Pharmacology and Therapeutics·F J MeyersM Konrad
Nov 7, 1995·Proceedings of the National Academy of Sciences of the United States of America·K C GilmourN C Reich
Sep 2, 2004·Nature Medicine·Steven A RosenbergNicholas P Restifo
Dec 8, 2007·Annual Review of Immunology·Thomas R Malek
Dec 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·James D PhelanFred D Finkelman
Sep 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Franz O SmithSteven A Rosenberg
Oct 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·Grégory VerdeilLinda A Sherman
Feb 6, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sven LétourneauOnur Boyman
Sep 9, 2010·Proceedings of the National Academy of Sciences of the United States of America·Timothy W HandSusan M Kaech
Jun 3, 2011·The New England Journal of Medicine·Douglas J SchwartzentruberPatrick Hwu
Apr 25, 2012·Cancer Immunology, Immunotherapy : CII·Kelly Barrios, Esteban Celis
Dec 18, 2012·Oncoimmunology·Laurence Zitvogel, Guido Kroemer
Dec 18, 2013·Immunological Reviews·Christian S Hinrichs, Steven A Rosenberg
Jan 7, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Toshihiro NagatoEsteban Celis
Jan 25, 2014·Cancer Immunology Research·Stephanie K DouganHidde L Ploegh
Jul 9, 2014·Nature Reviews. Clinical Oncology·Ignacio MeleroHåkan Mellstedt
Apr 22, 2015·The New England Journal of Medicine·Edward B GaronUNKNOWN KEYNOTE-001 Investigators
May 20, 2015·Cancer Immunology, Immunotherapy : CII·Zili Wang, Esteban Celis
Jan 7, 2016·Nature Medicine·Christopher A KlebanoffNicholas P Restifo
Feb 3, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Deborah H CharychStephen K Doberstein
Feb 13, 2016·Journal of Pharmaceutical Sciences·Peter L TurecekInge A Ivens
Apr 8, 2016·Cancer Immunology, Immunotherapy : CII·Hussein SultanEsteban Celis
Oct 11, 2016·The New England Journal of Medicine·Martin ReckUNKNOWN KEYNOTE-024 Investigators
Dec 13, 2016·Cancer Immunology Research·Takumi KumaiEsteban Celis
Oct 21, 2017·Oncotarget·Hussein SultanEsteban Celis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.